Multiply Labs Announces $20 Million Series A to Pioneer Robotic Manufacturing of Individualized Drugs Financing led by Casdin Capital, with participation from Lux Capital and Pathfinder, Founders Fund’s early stage investment vehicle to support the deployment of cloud-controlled robotic systems to enable drug production at industrial scale SAN FRANCISCO, April 14, 2021-- Multiply Labs, a robotics company developing automated manufacturing systems for the production of individualized drugs, announced today that it has raised $20 million in a Series A financing led by Casdin Capital.